Skip to content

Comparative study of low dose oxytocin and carbetocin regimens in elective caesarian sections

A Triple blind Randomised Controlled trial to compare low dose oxytocin and Carbetocin regimens in elective caesarean sections

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052533
Enrollment
60
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Carbetocin: A bolus of carbetocin 20mcg will be given intravenously over 1 minute, immediately after the delivery of the baby, followed by a placebo infusion till the caesarian section

Sponsors

CDSIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Full term pregnant women with singleton pregnancies coming for elective caesarian section

Exclusion criteria

Exclusion criteria: 1. Intrapartum caesarian sections. 2. Significant obstetric diseases like Gestational diabetes, Pre eclampsia, anemia. 3. Predisposing factors for post partum haemorrhage like uterine malformations, placental abnormalities, polyhydramnios, large baby, uterine fibroids, bleeding diatheses, previous history of post partum haemorrhage. 4.Allergy to the drugs used.

Design outcomes

Primary

MeasureTime frame
To determine the effectiveness of low dose carbetocin in achieving uterine contractionTimepoint: Uterine contraction is estimated by the obstetrician at the following time intervals after the administration of the bolus - 1 min, 3 min, 5 min, 10 min, 20 min, 30 min and immediately after the closure of the abdomen

Secondary

MeasureTime frame
Need for additional doses of carbetocin or oxytocinTimepoint: will be noted whenever administered, till the end of surgery;need for second line uterotonic drugs like Methylergometrine and CarboprostTimepoint: Shall be noted whenever administered, till the end of surgery;To determine the incidence of tachycardia and hypotensionTimepoint: Heart rate and blood pressure will be measured at 1 minute, 3 minutes and 5 minutes after administration of the bolus followed by measurements every 5 minutes till the end of surgery

Countries

India

Contacts

Public ContactDr Ajay S Shandilya

CDSIMER

ajay.anesthesia@gmail.com9071539089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026